Cannabis Stocks Surge as President Trump Considers Reclassifying Marijuana

Aug 11, 2025

Cannabis stocks rose sharply after reports surfaced that President Donald Trump is considering a policy change to reclassify marijuana as a less dangerous substance. According to The Wall Street Journal, President Trump recently told donors that he is interested in moving marijuana to a lower danger classification.

Currently, marijuana is classified as a Schedule I drug in the United States, alongside substances like heroin and cocaine. The potential change would move marijuana to Schedule III, which is considered less restrictive.

Major cannabis companies, such as Canopy Growth and Tilray Brands, saw their stock prices increase by over 12% following the news. Leaders in the cannabis industry, like UC Asset Limited Partnership, welcomed the possible policy shift, describing it as a positive development.

What does it mean to reclassify marijuana?

Reclassifying marijuana would change how the government views the drug, moving it from a group of the most dangerous drugs to one considered less risky.

Why did cannabis stocks go up after the news?

Investors are hopeful that a lower classification could make it easier for cannabis businesses to operate and grow, boosting their value.

Is this policy change official?

No, President Trump is reportedly considering the move, but no official decision has been made yet.

Sources
UC Asset Hails Pro-Cannabis Policy Development at President Trump's Office
PRNewsWire
ATLANTA , Aug. 11, 2025 /PRNewswire/ -- UC Asset Limited Partnership (OTCQB: UCASU) has issued a statement applauding the latest policy development from President Trump's office, as reported in an exclusive article by The Wall Street Journal on Saturday. The report, titled "Trump Weighs Reclassifyin...
Cannabis stocks rally on Wall Street Journal report that Trump is weighing drug...
CNBC
Cannabis stocks rallied on a Wall Street Journal report that President Donald Trump is contemplating reclassifying weed as having a lower danger level. Such a move would be "a gamechanger" for the industry, one investing chief said.
Cannabis stocks soar on Trump reclassification speculation
Invezz
Following a Wall Street Journal report, cannabis stocks surged Monday due to speculation that US President Donald Trump is considering reclassifying marijuana to a lower danger level. Canopy Growth and Tilray Brands both saw surges of over 12% on Monday.
Cannabis stocks surge as Trump consider reclassifying the drug
Proactive Investors
Cannabis stocks moved sharply higher on reports that President Donald Trump is considering rescheduling marijuana to a less restrictive drug category. The move would see marijuana reclassified from a Schedule I drug, along with heroin and cocaine, to Schedule III.
Cronos Rallies Amidst Greater Cannabis Sector Rally Over Possible Rescheduling
Seeking Alpha
Cannabis stocks rallied today over news of possible rescheduling by the Trump administration. Even though Cronos Group Inc. does not have a U.S. entry strategy, its stock price was up 15% on the news. Cronos reported improved financial performance last Thursday with higher revenues and improved inte...
Cannabis stocks rally after Trump says he is weighing drug reclassification
CNBC Television
Cannabis stocks rallied Monday after President Donald Trump said he is considering reclassifying marijuana, which would categorize it as less of a danger to public safety.
Tilray Brands: Is TLRY Stock The Next Big Thing?
Forbes
Tilray Brands (NASDAQ:TLRY), a pharmaceutical company that focuses on the production and distribution of medical and adult-use cannabis, craft beer, spirits, beverages, and hemp foods, offers an intriguing value opportunity after the stock surged by 42%, driven by regulatory optimism. The administra...
Top Ancillary Cannabis Stocks to Watch This Week as U.S. Legalization Momentum B...
MarijuanaStocks
The U.S. cannabis industry remains a powerful economic force, generating over $30 billion in annual sales in 2024. Industry analysts project sales could exceed $50 billion by 2030, driven by expanding legalization and rising consumer demand. Recently, headlines have focused on federal reform momentu...
Cannabis ETFs Soar as Trump Mulls Over Marijuana Reclassification
Zacks Investment Research
Cannabis ETFs like WEED, CNBS and MJ surge after Trump confirmed that his administration is weighing marijuana's move from Schedule I to Schedule III.
Top Canadian Marijuana Stocks If Federal Reform Passes In The USA
MarijuanaStocks
Marijuana stocks have begun to gain traction in trading, exhibiting moderate consistency. But why did this occur, and what is happening to bring such momentum to the sector? Once again, the backing and favorable side of passing federal reform for cannabis is being discussed by top politicians. In re...
Rescheduling Should Send MJ And MSOS Sky High
Seeking Alpha
Cannabis stocks and ETFs like Amplify Alternative Harvest ETF and AdvisorShares Pure US Cannabis ETF are surging on speculation that President Trump will reclassify marijuana as a Schedule III drug. Rescheduling would reduce regulatory and banking risks, potentially unlocking new capital and investo...
Show All Sources
Related Posts
Other News
Back to Top